Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions: Implications for oligodendrocyte pathology

American Journal of Pathology

Volumn 155, Issue 5, 1999, Pages 1433-1438

  Bonetti, Bruno ^a,b,c   Stegagno, Chiara ^b   Cannella, Barbara ^a   Rizzuto, Nicola ^b   Moretto, Giuseppe ^b   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERONA   (Italy)

^c POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; PROTEIN C JUN;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIPLE SCLEROSIS; NF-KAPPA B; OLIGODENDROGLIA; PROTO-ONCOGENE PROTEINS C-JUN; UP-REGULATION;

EID: 0032589563     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65456-9     Document Type: Article

References (29)

1. Raine CS: Demyelinating diseases. Textbook of Neuropathology, 3rd ed. Edited by Davis RL, Robertson DM. Baltimore, Williams & Wilkins, 1997, pp 627-714
2. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H: Distinct patterns of multiple sclerosis pathology indicate heterogeneity in pathogenesis. Brain Pathol 1996, 6:259-274
3. Raine CS: The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 1994, 36:561-572
4. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988, 23:339-346
5. Liu ZG, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK is not linked to apoptosis while NFκB activation prevents cell death. Cell 1996, 87:565-576
6. Grilli MG, Chiu JJ, Lenardo MJ: NFκB, and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143: 1-62
7. Bauerle PA. Baltimore D: NFκB: ten years later. Cell 1996, 87:13-20
8. O'Neill LAJ, Kaltschmidt C: NFκB: a crucial transcription factor for glial and neuronal cell function. Trends Neurol Sci 1997, 20:252-258
9. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad MF, Avruch J, Woodgett JR: The stress-activated protein kinase subfamily of c-jun kinases. Nature 1994, 369:156-160
10. Herdegen T, Skene P, Bahr M: The c-jun transcription factor: bipotential mediator of neuronal death, survival and regeneration. TINS 1997, 20:227-231
11. Gveric D, Kaltschmidt C, Cuzner ML, Newcombe J: Transcription factor NFκB and inhibitor IκBα are localized in macrophage in active MS lesions. J Neuropathol Exp Neurol 1998, 57:168-178
12. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Bauerle PA: Transcription factor NF-κB is activated in microglia during experimental encephalomyelitis. J Neuroimmunol 1994, 55:99-106
13. Bonetti B, Raine CS: Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997, 42:74-84
14. Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989, 170:607-612
15. Selmaj KW, Raine CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991, 87:949-954
16. Woodroofe MN, Cuzner ML: Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993, 5:583-588
17. Agresti C, Bernardo A, Del Russo N, Marziali G, Battistini A, Aloisi F, Levi G, Coccia EM: Synergistic stimulation of major histocompatibility complex class I and interferon regulatory factor 1 gene expression by interferon γ and tumor necrosis factor α in oligodendrocytes. Eur J Neurosci 1998, 10:2975-2983
18. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, Dubois-Dalcq M: In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type-1 encephalopathy. Ann Neurol 1995, 37:381-394
19. Louis JC, Megal E, Takayama S, Varon S: CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993, 259:689-692
20. D'Souza S, Alinauskas K, Mc Crea E, Goodyer C, Antel JP: Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 1995, 15:7293-7300
21. Prineas JW: The neuropathology of multiple sclerosis. Handbook of Clinical Neurology, vol. 47: Demyelinating Diseases. Edited by Koetsier JC. Amsterdam, Elsevier Science, 1985, pp 213-257
22. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple sclerosis: fas signalling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370
23. Bauer J, Wekerle H, Lassmann H: Apoptosis in brain-specific autoimmune disease. Curr Opin Immunol 1995, 7:839-843
24. Amer A, Baltimore D: An essential role for NFκB in preventing TNFα-induced cell death. Science 1996, 274:782-784
25. Wang CY, Mayo M, Baldwin A: TNF-, and cancer therapy-induced apoptosis potentiation by inhibition of NFκB. Science 1996, 274:784-787
26. Van Antwerp D, Martin S, Kafri T, Green DR, Verma IM: Suppression of TNFα-induced apoptosis by NFκB. Science 1996, 274:787-789
27. Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV: Competitive signaling between trkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 1998, 18:3273-3281
28. Ladiwala U, Lachance C, Simoneau S, Bhakar A, Barker PA, Antel JP: p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci 1998, 18:1297-1304
29. Zhang P, Miller BS, Rosenzweig SA, Bhat NR: Activation of c-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 1996, 46:114-121